Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets, Volume 19 - Number 1

Commentary   Open Access

Targeted Nanotechnology from Bench to Bedside

, 19(1): 3 - 4

Konstantinos Sapalidis, Christoforos Kosmidis, Stela Laskou, Athanasios Katsaounis, Stylianos Mantalobas, Ioannis Passos, Nikolaos Michalopoulos, Aikaterini Amaniti, Chrysa Sardeli and Paul Zarogoulidis*

DOI: 10.2174/156800961901181204130142

Review Article

Cutaneous Application of Celecoxib for Inflammatory and Cancer Diseases

, 19(1): 5 - 16

Oliesia Gonzalez Quiñones and Maria Bernadete Riemma Pierre*

DOI: 10.2174/1568009618666180430125201

Review Article

Review Article

Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?

, 19(1): 26 - 40

A.P. Alves, A.C. Mamede, M.G. Alves, P.F. Oliveira, S.M. Rocha, M.F. Botelho and C.J. Maia*

DOI: 10.2174/1568009618666180430144441

Systemic Review Article

Crizotinib Versus Chemotherapy on ALK-positive NSCLC: A Systematic Review of Efficacy and Safety

, 19(1): 41 - 49

Mingxia Wang, Guanqi Wang, Haiyan Ma and Baoen Shan*

DOI: 10.2174/1568009617666170623115846

Research Article

The Association of Neuronal Stress with Activating Transcription Factor 3 in Dorsal Root Ganglion of in vivo and in vitro Models of Bortezomib- Induced Neuropathy

, 19(1): 50 - 64

Yiting Yin, Xin Qi, Yuan Qiao, Huaxiang Liu, Zihan Yan, Hao Li and Zhen Liu*

DOI: 10.2174/1568009618666181003170027

Research Article

Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate

, 19(1): 65 - 73

Marzieh Ghanemi, Aminollah Pourshohod, Mohammad Ali Ghaffari, Alireza kheirollah, Mansour Amin, Majid Zeinali* and Mostafa Jamalan*

DOI: 10.2174/1568009617666170427105417

Research Article   Open Access

Related Journals

Related eBooks

eBooks Catalog